京都大学:痴呆鼻疫苗的开发:iPS细胞研究所

Alzheimer, IPS, Medical science

Roche-Actemra/RoActemra III期临床试验,用于重症COVID-19肺炎住院患者

flu, Medical science, Pharmaceutical

COVID-19:开发新的电晕疗法:参与全球联合试验

flu, Drugs, Medical science, Pharmaceutical

杏林制药:GeneSoC®的委托开发:日本医学研究与开发局(AMED)

flu, apparatus, catastrophe, Medical science, monitor

COVID-19:重病患者,在恢复ECMO的23名患者中有12名:300家医疗机构的调查

hospital, flu, apparatus, Medical science

Posts navigation